A promising molecule, called BT13, has offered hope for a new treatment that could stop or slow Parkinson’s, something no treatment can currently do.
Researchers from the University of Helsinki have found that molecule BT13 has the potential to both boost levels of dopamine, the chemical that is lost in Parkinson’s, as well as protecting the dopamine-producing brain cells from dying.
The results from the study, co-funded by Parkinson’s UK, showed an increase in dopamine levels in the brains of mice following treatment with the molecule. BT13 also activated a specific receptor in the mouse brains to protect the cells.
These findings suggest that BT13 could have the potential to lead to a new drug treatment that can slow, stop or even reverse the loss of brain cells in Parkinson’s.
Why is dopamine important?
Typically, by the time people are diagnosed with Parkinson’s, they have already lost 70-80 per cent of their dopamine-producing cells. These are involved in coordinating movement.
Current treatments mask the symptoms, but there is nothing that can slow down its progression or prevent more brain cells from being lost. As dopamine levels continue to fall, symptoms get worse and new symptoms can appear.
The role of BT13
Researchers are now working on improving the properties of BT13 to make it more effective as a potential treatment. If successful, this could benefit the 145,000 people living with Parkinson’s in the UK.
The study builds on previous research on another molecule that targets the same receptors in the brain, glial cell line-derived neurotrophic factor (GDNF), an experimental treatment for Parkinson’s which was the subject of a major clinical trial funded by Parkinson’s UK. While the results were not clear cut, GDNF has shown promise to restore damaged cells in Parkinson’s.
The GDNF protein requires complex surgery to deliver the treatment to the brain because it’s a large molecule. However BT13, a smaller molecule, could be more easily administered as a treatment if shown to be beneficial in further clinical trials.
“The molecule holds great promise”
Professor David Dexter, Deputy Director of Research at Parkinson’s UK, said: “People with Parkinson’s desperately need a new treatment that can stop the condition in its tracks, instead of just masking the symptoms.
“One of the biggest challenges for Parkinson’s research is how to get drugs past the blood-brain barrier, so the exciting discovery of BT13 has opened up a new avenue for research to explore.”
The Latest Updates from Bing News & Google News
Go deeper with Bing News on:
- Anavex Life Sciences Announces Participation at Upcoming Worldwide National Institutes of Health (NIH) Panel at Rare Disease Day(R)on February 22, 2021 at 8:34 pm
Rare Disease Day (R) takes place every year on the last day of February, with several international events extending into March. The event at the NIH is sponsored by the National Center for Advancing ...
- Man who suffers from Alzheimer's and Parkinson's disease reported missing in Woodstock found safeon February 22, 2021 at 4:43 pm
Woodstock Police need the public's help locating a missing man on Sunday. Carlton Brevard was last seen in the area of the Alta Ridgewalk Apartments, they said on social media. Brevard is on foot and ...
- Family Physical Therapy offers Parkinson's supporton February 22, 2021 at 3:00 am
Dr. Emily Afrank with Family Physical Therapy at Fountain Point says they’re certified in the nationwide ‘BIG and LOUD’ program. Afrank says they’ve seen a lot of progress from patients who’ve taken ...
- TWAS x GWAS? Transcriptome Analysis Finds 11 Parkinson’s Geneson February 20, 2021 at 2:45 pm
First PWAS for AD, now TWAS for PD. Hot on the heels of a study that linked AD variants to changes in a protein-wide association study (Feb 2021 news), geneticists now have linked Parkinson’s ...
- Parkinson’s Foundation program helps local residentson February 20, 2021 at 6:30 am
The Parkinson’s Foundation is hosting a virtual online program Young Onset Parkinson’s Disease: You Are Not Alone on Saturday, Feb. 27 from 10 a.m. to 12:30 p.m. in collaboration with ...
Go deeper with Google Headlines on:
Go deeper with Bing News on:
- The 15 Northern Ireland postcodes hardest hit by coronavirus in the last 7 dayson February 22, 2021 at 10:44 pm
The Northern Ireland postcodes where coronavirus spread most between February 15 to 21 have been revealed by the Department of Health. Its latest dashboard updates shows that in the seven days up to ...
- Raiders target Falkirk car showroom as three vehicles stolenon February 21, 2021 at 12:09 pm
Three vehicles have been stolen in a late-night raid on a car showroom in Camelon, leaving local business owners facing a bill of £50,000.
- PTT's profit slumps 60 per cent year on year in 2020on February 18, 2021 at 8:49 pm
PTT Pcl on Thursday reported a net profit of Bt13.14 billion in the fourth quarter of 2020, down 6.96 per cent or Bt973 million from the previous quarter.
- The 15 Northern Ireland postcodes hardest hit by coronavirus in the last 7 dayson February 15, 2021 at 8:49 am
BT71 Coalisland, Dungannon and Ardboe - 145 cases - 1,004 tested BT62 Portadown and Tandragee - 97 cases - 611 tested BT41 Antrim and Randalstown - 88 cases - 864 tested BT13 Shankill Road and ...
- Lunch budget to be increased to Bt21 per student per dayon February 9, 2021 at 7:50 pm
A Cabinet meeting on Tuesday approved a motion proposed by the Education Ministry to increase the lunch budget for students by 5 per cent, or to Bt21 per person per day, government spokesman Anucha ...